ANI Pharmaceuticals, Inc. (ANIP)

55.10 -1.63 (-2.87%) At close: 04:00PM EDT

ANI Pharmaceuticals, Inc.

210 Main Street West
Baudette, MN 56623
United States
218 634 3500
https://www.anipharmaceuticals.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 642

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Nikhil Lalwani	President, CEO & Director	2.32M	373.22k	1978
Mr. Stephen P. Carey	Senior VP of Finance & CFO	1.11M	N/A	1971
Mr. Chad Gassert	Senior Vice President of Corporate Development & Strategy	849.71k	N/A	1976
Mr. Christopher K. Mutz	Senior Vp & Head of Rare Disease	867.92k	N/A	1972
Mr. Ori Gutwerg	Senior Vice President of Generics	895.16k	436.25k	1975
Mr. Muthusamy Shanmugam MS R.Ph.	Head of R&D, COO of Novitium Operations & Director	N/A	N/A	1968
Mr. James G. Marken	Senior Vice President of Operations	673.23k	N/A	1963
Ms. Elizabeth Powell J.D.	Chief Compliance Officer & Head of Legal of Rare Disease	N/A	N/A	N/A
Ms. Meredith W. Cook	Senior VP, General Counsel & Corporate Secretary	N/A	N/A	1975
Ms. Krista L. Davis	Senior VP & Chief Human Resources Officer	N/A	N/A	1974

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Corporate governance

ANI Pharmaceuticals, Inc.’s ISS governance QualityScore as of 1 October 2024 is 2. The pillar scores are Audit: 9; Board: 3; Shareholder rights: 1; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.